2018 Q4 Form 10-Q Financial Statement

#000114420418060006 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.390M $820.0K $850.0K
YoY Change 26.36% -3.53% 325.0%
% of Gross Profit
Research & Development $2.720M $1.788M $2.000M
YoY Change -47.89% -10.6% 992.9%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.100M $1.788M $2.848M
YoY Change -35.18% -37.22% 643.6%
Operating Profit -$2.608M -$2.848M
YoY Change -8.43% 643.6%
Interest Expense $10.00K $0.00 $106.0K
YoY Change -87.5% -100.0% 19.1%
% of Operating Profit
Other Income/Expense, Net $180.0K $0.00 -$100.0K
YoY Change 119.51% -100.0% -37.89%
Pretax Income -$3.920M -$2.600M -$2.950M
YoY Change -37.18% -11.86% 446.3%
Income Tax
% Of Pretax Income
Net Earnings -$3.920M -$2.595M -$2.948M
YoY Change -37.21% -11.97% 441.91%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$380.2K -$252.4K -$295.9K
COMMON SHARES
Basic Shares Outstanding 10.66M shares 10.55M shares 10.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.670M $4.800M $26.05M
YoY Change -87.74% -81.57% 86733.33%
Cash & Equivalents $2.671M $4.804M $16.05M
Short-Term Investments $0.00 $0.00 $10.00M
Other Short-Term Assets $1.850M $460.0K $130.0K
YoY Change 374.36% 253.85% 333.33%
Inventory
Prepaid Expenses $126.0K
Receivables
Other Receivables
Total Short-Term Assets $4.530M $5.260M $26.18M
YoY Change -79.57% -79.91% 43533.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$5.000K $3.000K -$4.000K
YoY Change -175.0%
TOTAL ASSETS
Total Short-Term Assets $4.530M $5.260M $26.18M
Total Long-Term Assets -$5.000K $3.000K -$4.000K
Total Assets $4.525M $5.263M $26.18M
YoY Change -79.59% -79.89% 43526.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.089M $770.0K $1.910M
YoY Change 99.94% -59.69% 377.5%
Accrued Expenses $2.070M $1.700M $80.00K
YoY Change 4040.0% 2025.0% -94.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $5.156M $2.469M $1.990M
YoY Change 84.8% 24.07% -58.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.156M $2.469M $1.990M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.156M $2.469M $1.990M
YoY Change 84.8% 24.07% -73.64%
SHAREHOLDERS EQUITY
Retained Earnings -$42.21M -$38.29M -$14.42M
YoY Change 104.29% 165.57%
Common Stock $41.58M $41.08M $38.60M
YoY Change 6.78% 6.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$631.0K $2.794M $24.19M
YoY Change
Total Liabilities & Shareholders Equity $4.525M $5.263M $26.18M
YoY Change -79.59% -79.89% 43526.67%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$3.920M -$2.595M -$2.948M
YoY Change -37.21% -11.97% 441.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.240M -$4.140M -$1.870M
YoY Change -70.96% 121.39% 325.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$10.00M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$10.00M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -900.0K 0.000 -6.750M
YoY Change -100.0% -1600.0%
NET CHANGE
Cash From Operating Activities -1.240M -4.140M -1.870M
Cash From Investing Activities 0.000 0.000 -10.00M
Cash From Financing Activities -900.0K 0.000 -6.750M
Net Change In Cash -2.140M -4.140M -18.62M
YoY Change -49.88% -77.77% -186300.0%
FREE CASH FLOW
Cash From Operating Activities -$1.240M -$4.140M -$1.870M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-5096000 USD
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q3 atxi Common Stock Value Issuable
CommonStockValueIssuable
0 USD
CY2017Q4 atxi Common Stock Value Issuable
CommonStockValueIssuable
1103000 USD
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41083000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38937000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38290000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20661000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
2794000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19380000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5263000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22170000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2469000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2790000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
2469000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
2790000 USD
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4804000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11782000 USD
CY2018Q3 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
10000000 USD
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
388000 USD
CY2018Q3 us-gaap Assets
Assets
5263000 USD
CY2017Q4 us-gaap Assets
Assets
22170000 USD
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2098000 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2737000 USD
CY2018Q3 atxi Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
371000 USD
CY2017Q4 atxi Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
53000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1788000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14981000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2580000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
820000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
848000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2733000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2516000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2608000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2848000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17714000 USD
CY2018Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2017Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
85000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
0 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
106000 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
294000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
81000 USD
CY2018Q3 atxi Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
0 USD
CY2017Q3 atxi Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
0 USD
atxi Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
0 USD
atxi Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
99000 USD
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
451000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-2595000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-2948000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17629000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6015000 USD
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.73
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.09
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10295958 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9972663 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10216466 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5514988 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
atxi Share Issued During Period Valueon Exercise Of Warrants
ShareIssuedDuringPeriodValueonExerciseOfWarrants
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1043000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1043000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
270000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
174000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
71000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
126000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-639000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1408000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
318000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
360000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-57000 USD
atxi Accrued Interest Related Party
AccruedInterestRelatedParty
0 USD
atxi Accrued Interest Related Party
AccruedInterestRelatedParty
-46000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16978000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2534000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28387000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-6978000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
15853000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
197000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16050000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
297000 USD
atxi Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
0 USD
atxi Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
948000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37950000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3715000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
1000000 USD
atxi Warrants Issued
WarrantsIssued
0 USD
atxi Warrants Issued
WarrantsIssued
750000 USD
atxi Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
0 USD
atxi Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
632000 USD
atxi Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
0 USD
atxi Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
300000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
200000 USD
atxi Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
0 USD
atxi Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
15000 USD
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
250000 shares
CY2016Q3 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.025 pure
CY2017 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1100000 USD
CY2016 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
49000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1391310 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
984999 shares
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
770000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1545000 USD
CY2018Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
216000 USD
CY2017Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
215000 USD
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1112000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
977000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.29
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M17D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M17D
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10265083 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10662398 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10265083 shares
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-10000000 USD
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
10000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3000000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2848000 USD
CY2017Q4 atxi Common Stock Shares Issuable
CommonStockSharesIssuable
273837 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0.05in; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10662398 shares
CY2018Q3 atxi Common Stock Shares Issuable
CommonStockSharesIssuable
0 shares
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
CY2018Q3 atxi Service Agreement Expenses
ServiceAgreementExpenses
100000 USD
atxi Service Agreement Expenses
ServiceAgreementExpenses
400000 USD
CY2017Q3 atxi Service Agreement Expenses
ServiceAgreementExpenses
100000 USD
atxi Service Agreement Expenses
ServiceAgreementExpenses
400000 USD
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
AVENUE THERAPEUTICS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001644963
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Trading Symbol
TradingSymbol
ATXI
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10662398 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Small Business
EntitySmallBusiness
false

Files In Submission

Name View Source Status
0001144204-18-060006-index-headers.html Edgar Link pending
0001144204-18-060006-index.html Edgar Link pending
0001144204-18-060006.txt Edgar Link pending
0001144204-18-060006-xbrl.zip Edgar Link pending
atxi-20180930.xml Edgar Link completed
atxi-20180930.xsd Edgar Link pending
atxi-20180930_cal.xml Edgar Link unprocessable
atxi-20180930_def.xml Edgar Link unprocessable
atxi-20180930_lab.xml Edgar Link unprocessable
atxi-20180930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv506527_10q.htm Edgar Link pending
tv506527_ex31-1.htm Edgar Link pending
tv506527_ex31-2.htm Edgar Link pending
tv506527_ex32-1.htm Edgar Link pending
tv506527_ex32-2.htm Edgar Link pending